These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3782466)

  • 41. Production of overmodified type I procollagen in a case of osteogenesis imperfecta.
    Tajima S; Takehana M; Azuma N
    J Dermatol; 1994 Apr; 21(4):219-22. PubMed ID: 8056893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.
    Tenni R; Biglino P; Dyne K; Rossi A; Filocamo M; Pendola F; Brunelli P; Buttitta P; Borrone C; Cetta G
    J Inherit Metab Dis; 1991; 14(2):189-201. PubMed ID: 1886404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.
    Wenstrup RJ; Willing MC; Starman BJ; Byers PH
    Am J Hum Genet; 1990 May; 46(5):975-82. PubMed ID: 2339695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A tripeptide deletion in the triple-helical domain of the pro alpha 1(I) chain of type I procollagen in a patient with lethal osteogenesis imperfecta does not alter cleavage of the molecule by N-proteinase.
    Wallis GA; Kadler KE; Starman BJ; Byers PH
    J Biol Chem; 1992 Dec; 267(35):25529-34. PubMed ID: 1460047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
    Chessler SD; Wallis GA; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta.
    Pace JM; Atkinson M; Willing MC; Wallis G; Byers PH
    Hum Mutat; 2001 Oct; 18(4):319-26. PubMed ID: 11668615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
    Bonadio J; Byers PH
    Nature; 1985 Jul 25-31; 316(6026):363-6. PubMed ID: 4022126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.
    Byers PH; Shapiro JR; Rowe DW; David KE; Holbrook KA
    J Clin Invest; 1983 Mar; 71(3):689-97. PubMed ID: 6826730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered helical structure of a homotrimer of alpha 1(I)chains synthesized by fibroblasts from a variant of osteogenesis imperfecta.
    Deak SB; van der Rest M; Prockop DJ
    Coll Relat Res; 1985 Sep; 5(4):305-13. PubMed ID: 4053561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta.
    Williams CJ; Prockop DJ
    J Biol Chem; 1983 May; 258(9):5915-21. PubMed ID: 6304100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.
    Wallis GA; Starman BJ; Zinn AB; Byers PH
    Am J Hum Genet; 1990 Jun; 46(6):1034-40. PubMed ID: 2339700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.
    Rowe DW; Shapiro JR; Poirier M; Schlesinger S
    J Clin Invest; 1985 Aug; 76(2):604-11. PubMed ID: 4031065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies.
    Prockop DJ; Colige A; Helminen H; Khillan JS; Pereira R; Vandenberg P
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S489-92. PubMed ID: 8122517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cysteine in the triple helical domain of the pro alpha 2(I) chain of type-I collagen in nonlethal forms of osteogenesis imperfecta.
    Cohn DH; Byers PH
    Hum Genet; 1991 Jun; 87(2):167-72. PubMed ID: 2066103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen.
    Valli M; Tenni R; Cetta G
    Matrix; 1990 Jul; 10(3):200-5. PubMed ID: 2215359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel mutation causes a perinatal lethal form of osteogenesis imperfecta. An insertion in one alpha 1(I) collagen allele (COL1A1).
    Byers PH; Starman BJ; Cohn DH; Horwitz AL
    J Biol Chem; 1988 Jun; 263(16):7855-61. PubMed ID: 3372508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta.
    Nicholls AC; Oliver J; Renouf DV; Keston M; Pope FM
    J Med Genet; 1991 Nov; 28(11):757-64. PubMed ID: 1770532
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.
    Deak SB; Nicholls A; Pope FM; Prockop DJ
    J Biol Chem; 1983 Dec; 258(24):15192-7. PubMed ID: 6418743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.
    de Wet WJ; Pihlajaniemi T; Myers J; Kelly TE; Prockop DJ
    J Biol Chem; 1983 Jun; 258(12):7721-8. PubMed ID: 6863261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.